Barr pulls application for generic Premarin
Barr will withdraw its ANDA for a generic of Wyeth's Premarin (conjugated estrogens) after an appeals court affirmed a ruling against Barr's raw materials supplier. In a decision issued Jan. 24, a St. Louis, Mo. federal appeals court upheld a 2003 decision by a St. Paul, Minn. district court that found that Natural Biologics misappropriated trade secrets from Wyeth (1"The Pink Sheet" Oct. 13, 2003, p. 25)....
You may also be interested in...
Natural Biologics lacks the expertise to reproduce Wyeth's estrogen extraction process for conjugated estrogens (Premarin) by legitimate means, St. Paul, Minn. federal court Judge Joan Ericksen maintained in issuing a permanent injunction against the company
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.